Jeevan Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.10 Cr
as on 23-10-2024
- Paid Up Capital ₹ 5.04 Cr
as on 23-10-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 29.35 Cr
as on 23-10-2024
- Revenue 15.61%
(FY 2023)
- Profit 9.74%
(FY 2023)
- Ebitda 8.88%
(FY 2023)
- Net Worth 51.93%
(FY 2023)
- Total Assets 18.80%
(FY 2023)
About Jeevan Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.10 Cr and a paid-up capital of Rs 5.04 Cr.
The company currently has active open charges totaling ₹17.00 Cr. The company has closed loans amounting to ₹29.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sonir Shah and Ashita Shah serve as directors at the Company.
- CIN/LLPIN
U24100MH2005PTC151145
- Company No.
151145
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Jeevan Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonir Shah  | Director | 09-Feb-2005 | Current |
| Ashita Shah | Director | 09-Feb-2005 | Current |
Financial Performance and Corporate Structure Insights of Jeevan Chemicals.
Jeevan Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.61% increase. The company also saw a slight improvement in profitability, with a 9.74% increase in profit. The company's net worth Soared by an impressive increase of 51.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jeevan Chemicals?
In 2023, Jeevan Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Aug 2023 | ₹5.00 Cr | Open |
Others Creation Date: 25 Sep 2020 | ₹12.00 Cr | Open |
Others Creation Date: 25 Sep 2020 | ₹1.98 Cr | Satisfied |
How Many Employees Work at Jeevan Chemicals?
Jeevan Chemicals has a workforce of 36 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeevan Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeevan Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
